These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36318037)

  • 1. Durable spike-specific T cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination.
    Maringer Y; Nelde A; Schroeder SM; Schuhmacher J; Hörber S; Peter A; Karbach J; Jäger E; Walz JS
    Sci Immunol; 2022 Dec; 7(78):eadd3899. PubMed ID: 36318037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-spike and spike-specific memory T cell responses after the third dose of inactivated COVID-19 vaccine.
    Huang R; Ying L; Wang J; Xia J; Zhang Y; Mao H; Zhang R; Zang R; Le Z; Shu Q; Xu J
    Front Immunol; 2023; 14():1139620. PubMed ID: 37114058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants.
    Chen Y; Chen L; Yin S; Tao Y; Zhu L; Tong X; Mao M; Li M; Wan Y; Ni J; Ji X; Dong X; Li J; Huang R; Shen Y; Shen H; Bao C; Wu C
    Emerg Microbes Infect; 2022 Dec; 11(1):1524-1536. PubMed ID: 35608053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of boosted mRNA and adenoviral-vectored vaccines on immune responses to omicron BA.1 and BA.2 following the heterologous CoronaVac/AZD1222 vaccination.
    Suntronwong N; Kanokudom S; Auphimai C; Assawakosri S; Thongmee T; Vichaiwattana P; Duangchinda T; Chantima W; Pakchotanon P; Chansaenroj J; Puenpa J; Nilyanimit P; Srimuan D; Thatsanatorn T; Sudhinaraset N; Wanlapakorn N; Mongkolsapaya J; Poovorawan Y
    J Med Virol; 2022 Dec; 94(12):5713-5722. PubMed ID: 35924475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent memory despite rapid contraction of circulating T Cell responses to SARS-CoV-2 mRNA vaccination.
    Taus E; Hofmann C; Ibarrondo FJ; Gong LS; Hausner MA; Fulcher JA; Krogstad P; Kitchen SG; Ferbas KG; Tobin NH; Rimoin AW; Aldrovandi GM; Yang OO
    Front Immunol; 2023; 14():1100594. PubMed ID: 36860850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
    Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G
    Front Immunol; 2022; 13():863554. PubMed ID: 35711445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boosting with Multiple Doses of mRNA Vaccine after Priming with Two Doses of Protein Subunit Vaccine MVC-COV1901 Elicited Robust Humoral and Cellular Immune Responses against Emerging SARS-CoV-2 Variants.
    Chiu CH; Chang YH; Tao CW; Chang FY; Chiu KC; Chang TW; Yen LC
    Microbiol Spectr; 2022 Oct; 10(5):e0060922. PubMed ID: 36005765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal monitoring of mRNA-vaccine-induced immunity against SARS-CoV-2.
    Monzon-Posadas WO; Zorn J; Peters K; Baum M; Proksch H; Schlüter CB; Menting T; Pušnik J; Streeck H
    Front Immunol; 2023; 14():1066123. PubMed ID: 36742295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response.
    Storti P; Marchica V; Vescovini R; Franceschi V; Russo L; Notarfranchi L; Raimondi V; Toscani D; Burroughs Garcia J; Costa F; Dalla Palma B; Iannozzi NT; Sammarelli G; Donofrio G; Giuliani N
    Oncoimmunology; 2022; 11(1):2120275. PubMed ID: 36105747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8
    van den Dijssel J; Duurland MC; Konijn VA; Kummer LY; Hagen RR; Kuijper LH; Wieske L; van Dam KP; Stalman EW; Steenhuis M; Geerdes DM; Mok JY; Kragten AH; Menage C; Koets L; Veldhuisen B; Verstegen NJ; van der Schoot CE; van Esch WJ; D'Haens GR; Löwenberg M; Volkers AG; Rispens T; Kuijpers TW; Eftimov F; van Gisbergen KP; van Ham SM; Ten Brinke A; van de Sandt CE;
    J Autoimmun; 2024 Apr; 144():103175. PubMed ID: 38387105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants.
    Lam JY; Ng YY; Yuen CK; Wong WM; Yuen KY; Kok KH
    Emerg Microbes Infect; 2022 Dec; 11(1):964-967. PubMed ID: 35275039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody and T-cellular response to COVID-19 booster vaccine in SARS-CoV-1 survivors.
    Lu BN; Zhu KL; Cui XM; Yao L; Wang XJ; Wang GL; Duan LJ; Qian A; Ma MJ
    Clin Immunol; 2022 Nov; 244():109103. PubMed ID: 36049602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
    Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
    Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological study of CoronaVac vaccine and booster doses in Chile: immunogenicity and persistence of anti-SARS-CoV-2 spike antibodies.
    Vargas L; Valdivieso N; Tempio F; Simon V; Sauma D; Valenzuela L; Beltrán C; Castillo-Delgado L; Contreras-Benavides X; Acevedo ML; Acevedo J; Gonzalez RI; Valiente-Echeverría F; Soto-Rifo R; Rosemblatt M; Lopez M; Osorio F; Bono MR
    BMC Med; 2022 Jun; 20(1):216. PubMed ID: 35676738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Homologous and Heterologous Booster SARS-CoV-2 Vaccination in Autoimmune Rheumatic and Musculoskeletal Patients.
    Honfi D; Gémes N; Szabó E; Neuperger P; Balog JÁ; Nagy LI; Toldi G; Puskás LG; Szebeni GJ; Balog A
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern.
    Schultz BM; Melo-González F; Duarte LF; Gálvez NMS; Pacheco GA; Soto JA; Berríos-Rojas RV; González LA; Moreno-Tapia D; Rivera-Pérez D; Ríos M; Vázquez Y; Hoppe-Elsholz G; Andrade-Parra CA; Vallejos OP; Piña-Iturbe A; Iturriaga C; Urzua M; Navarrete MS; Rojas Á; Fasce R; Fernández J; Mora J; Ramírez E; Gaete-Argel A; Acevedo ML; Valiente-Echeverría F; Soto-Rifo R; Weiskopf D; Grifoni A; Sette A; Zeng G; Meng W; ; González-Aramundiz JV; González PA; Abarca K; Kalergis AM; Bueno SM
    mBio; 2022 Aug; 13(4):e0142322. PubMed ID: 35946814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals.
    Goh YS; Rouers A; Fong SW; Zhuo NZ; Hor PX; Loh CY; Huang Y; Neo VK; Kam IKJ; Wang B; Ngoh EZX; Salleh SNM; Lee RTC; Pada S; Sun LJ; Ong DLS; Somani J; Lee ES; ; ; Maurer-Stroh S; Wang CI; Leo YS; Ren EC; Lye DC; Young BE; Ng LFP; Renia L
    Front Immunol; 2022; 13():1031852. PubMed ID: 36451833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens.
    Hielscher F; Schmidt T; Klemis V; Wilhelm A; Marx S; Abu-Omar A; Ziegler L; Guckelmus C; Urschel R; Sester U; Widera M; Sester M
    J Clin Virol; 2022 Dec; 157():105321. PubMed ID: 36279695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 spike glycoprotein-reactive T cells can be readily expanded from COVID-19 vaccinated donors.
    Taborska P; Lastovicka J; Stakheev D; Strizova Z; Bartunkova J; Smrz D
    Immun Inflamm Dis; 2021 Dec; 9(4):1452-1467. PubMed ID: 34314576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral and adaptive immune responses to the SARS-CoV-2 vaccine.
    Rizzo R; Bortolotti D; Morandi L; Rizzo S; Schiuma G; Beltrami S; Papi A; Contoli M
    Int J Infect Dis; 2022 Sep; 122():412-414. PubMed ID: 35750264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.